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Abstract
Innate immune mechanisms are crucial in defense against bacterial illnesses in humans, as
evidenced by abnormal antibacterial responses due to defects in TLR signaling, seen in children
with MyD88 or IL-1R–associated kinase 4 deficiency. Otitis media (OM) is the most common
disease of childhood, and the role of innate immune molecules in this disorder remains unclear. In
a murine model of OM, we show that, in the absence of TNF, a key effector of innate immunity,
this disease is prolonged after middle ear infection with nontypeable Haemophilus influenzae
(NTHi). In the absence of TNF, mice fail to upregulate both TLRs and downstream genes and
proteins, such as CCL3, resulting in defects in both inflammatory cell recruitment and macrophage
function. Peritoneal macrophages of mice lacking TNF have a diminished ability to phagocytose
and kill NTHi, and this defect is partially corrected in vitro by exogenous rTNF. Addition of
Address correspondence and reprint requests to Dr. Allen F. Ryan, University of California, San Diego, 9500 Gilman Drive, MC
#0666, La Jolla, CA 92093-0666. afryan@ucsd.edu.
1A.L. and M.H. contributed equally to this work.
2A.F.R. and S.I.W. contributed equally to the supervision of this work.
Disclosures
A.F.R. and R.G. are part-time federal government employees at the San Diego Veterans Affairs Medical Center.
The online version of this article contains supplemental material.
Corrections
Leichtle, A., M. Hernandez, J. Ebmeyer, K. Yamasaki, Y. Lai, K. Radek, Y.-H. Choung, S. Euteneuer, K. Pak, R. Gallo, S. I.
Wasserman, and A. F. Ryan. 2010. CC chemokine ligand 3 overcomes the bacteriocidal and phagocytic defect of macrophages and
hastens recovery from experimental otitis media in TNF−/− mice. J. Immunol. 184: 3087–3097.




J Immunol. Author manuscript; available in PMC 2011 March 15.
Published in final edited form as:













rCCL3 alone or in combination with rTNF restores phagocytosis and killing by TNF-deficient
macrophages to that of unstimulated wild-type macrophages. In vivo administration of rCCL3 to
animals deficient in TNF fully restores the ability to control OM due to NTHi, whereas a CCL3-
blocking Ab impaired the ability of wild-type mice to recover from OM. Thus, CCL3 is a potent
downstream effector of TNF-mediated inflammation in vitro and in vivo. Manipulation of CCL3
and/or TNF may prove to be effective therapeutic approaches in OM or other conditions
associated with defective TNF generation.
Otitis media (OM) is the most prevalent disease of childhood and a major public health
problem contributing to childhood mortality in less developed countries (1-3). In developed
societies, OM accounts for more office visits and drug purchases than any other disease in
the first 6 y of life and is the most common reason for outpatient antimicrobial treatment in
the United States, with a cost of >$5 billion per year (4-6). Although acute OM is generally
an uncomplicated and self-limited disease, chronic OM is difficult to manage and frequently
results in continuous medical treatment and/or multiple surgical procedures with serious
sequelae, including recurrent or irreversible pain and long-term hearing loss with consequent
delay of language development and academic achievement (7,8).
The precise pathogenesis of OM, considered to be multifactorial, is still poorly understood.
However, our group and others have demonstrated that innate immune mechanisms are
intimately involved in host defense in murine models of OM. Defense against OM, in a
murine model, is defective in the absence of MyD88, TLR2, or TLR4 (9,10). In children,
genetic polymorphisms in TLR4 and the TLR coreceptor CD14 are associated with an
increased incidence of OM (11-13). Nontypeable Haemophilus influenzae (NTHi) is a major
cause of human disease, including OM (14), and also contributes to exacerbation of chronic
obstructive pulmonary disease (15). TLR2 mediates responses upon exposure to bacterial
products including peptidoglycan, lipoteichoic acid, lipoarabinomannan, and lipoprotein
from Gram-negative bacteria, such as NTHi (16-18). Following bacterial ligand binding,
TLRs activate various transcription factors, such as NF-κB (19,20), to mediate expression of
genes encoding inflammatory cytokines including TNF, IL-1β, IL6, and the chemokines
CXCL2 (MIP-2) and CCL3 (MIP-1α) (21,22).
We have reported that the prolonged inflammatory responses of TLR2−/− and TLR4−/− mice
during experimental OM are associated with defective induction of TNF (10). TNF is a
pleiotropic inflammatory cytokine known to be a major mediator of inflammation (e.g., see
Ref. 23), and previous work suggests a pathophysiological role for this mediator in OM.
Transtympanic injection of TNF into the middle ears (MEs) of guinea pigs induces
inflammation (24), whereas administration of a TNF antagonist, soluble TNF receptor type
I, reduces the severity of LPS-, TNF-, and immune-mediated OM in rats (25-28).
Polymorphisms in the TNF promoter that alter TNF production have been associated with an
increased incidence of OM in children, suggesting that variability in TNF concentrations
may alter susceptibility to and/or expression of OM (11,13,29,30).
TNF has been shown to regulate the expression of TLRs and molecules essential for TLR
signaling, including NF-κB, via both positive (21) and negative (31) feedback mechanisms.
Thus, TNF may modulate innate immunity and the complex networks of downstream
cytokines and chemokines and participate in the orchestration of the inflammatory response
by regulating the migration, activation, and biological properties of various effector cells,
particularly mononuclear phagocytes, and neutrophilic polymorphonuclear leukocytes
(32,33). For example, TNF directly stimulates production of CCL3, a member of the CC
chemokine family known to be an important chemotactic and regulatory agent for
macrophages (34,35), and TNF also enables neutrophilic migration in response to CCL3
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(33). Neutrophil and mononuclear leukocyte migration into the ME cavity is a central
feature of the normal response of mice to NTHi-mediated OM.
We therefore investigated the role of TNF in a well-established murine model of OM
induced by NTHi infection of the ME. Our results reveal an important role for TNF in host
defense against NTHi-induced OM, in part due to defective bacterial phagocytosis and
killing by macrophages of TNF−/− mice. In addition, we have uncovered the ability of
rCCL3 to overcome defects in phagocytosis and bacterial killing in macrophages obtained
from TNF−/− mice in vitro and to restore an appropriate antibacterial response to NTHi-
induced OM in vivo. These data suggest that migration, phagocytosis, and bacterial killing
by macrophages is, in part, dependent upon normal levels of TNF and that CCL3 is an
important downstream effector of TNF action in OM.
Materials and Methods
Animals
TNF−/− mice (B6/129S6-Tnftm1Gkl/J) and age-matched wild-type (WT) controls (B6/129S
F2 hybrids) were obtained from The Jackson Laboratory (Bar Harbor, ME). TLR2−/− mice,
originally generated on a C57BL/6 background by Akira and colleagues (36), were bred in
our laboratory. Age-matched C57BL/6 mice were purchased from The Jackson Laboratory.
All animals were housed in specific pathogen-free conditions. Experimental protocols were
approved by the Institutional Animal Care and Use Committee of the Veterans Affairs
Medical Center, San Diego, CA.
Bacterial strains and culture conditions
Nontypeable Haemophilus influenzae strain 3655 (NTHi, biotype II) was used at a
concentration of 105 to 106/ml in ~5 μl to induce infection of the ME. The inocula were
prepared as previously described (37).
Surgical procedure
Mice were anesthetized with an i.p. injection of 0.1–0.2 ml per 30 g body weight of rodent
mixture (13.3 mg/ml ketamine HCl, 1.3 mg/ml xylazine, and 0.25 mg/ml acepromazine).
ME bullae were exposed bilaterally by a ventral approach through a midline incision on the
neck, and the ME bulla was fenestrated using a 25-gauge needle. A total of 5 × 102–103
NTHi in ~5 μl was injected into the ME cavity. Excess fluid was absorbed with a sterile
cotton swab. The wound was closed, and the skin incision was stapled. The animals received
s.c. injections of buprenorphine and lactated Ringers solution postoperatively.
Quantitative real-time PCR
For mucosal gene expression, total RNA from 6–8 NTHi-injected MEs from TNF−/−,
TLR2−/−, and WT mice per time point, was extracted using the Dynabeads mRNA Direct kit
(Invitrogen, Carlsbad, CA). A total of 20 μl mRNA solution was reverse transcribed using
the SuperScript First-Strand cDNA Synthesis kit (Invitrogen). Six hours post NTHi
infection, total RNA from macrophages was extracted using TRIzol, and 1 μg RNA was
transcribed with iScript (Bio-Rad, Hercules, CA). Quantitative real-time PCR (qRT-PCR)
was performed using 1 μg/μl mRNA and predeveloped Taq-Man assay probes (Applied
Biosystems, Foster City, CA) for murine TNF, IL-1β, IL6, CXCL2, CCL3, TLR2, and TLR4
in the Applied Biosystems Prism 7000 Sequence Detection System (Applied Biosystems)
according to the manufacturer’s protocol. All analyses were performed in triplicate from two
to three independent experiments, and the fold induction was calculated using the
comparative threshold cycle method as previously described (38). Relative expression levels
were normalized to GAPDH and compared with untreated and uninfected mucosa or cells.
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Mice were sacrificed under general anesthesia by intracardiac perfusion with PBS followed
by 4% paraformaldehyde (PFA) at 0, 6, and 12 h and 1, 2, 3, 5, 10, 14, and 21 d
postinoculation. MEs were dissected, postfixed (4% PFA) overnight, and decalcified (8%
EDTA and 4% PFA) for 14 d. ME bullae were embedded in paraffin and sections were cut
at 7 μm. Sections were stained with H&E, digitally recorded, and the grade of OM was
quantified by evaluation of mucosal thickness and leukocyte recruitment as described
previously (9). Macrophage counts were confirmed on separate sections by F4/80 staining.
Immunostaining for F4/80
Paraffin-fixed sections were rehydrated, microwaved in Ag retrieval solution (0.01 M citric
acid, 0.05 M NaOH [pH 6.0]) for 4 min, and incubated in 3% H2O2 in water to block
endogenous peroxidases. Sections were blocked in normal goat serum for 30 min (1:10) in
PBS and 3% BSA and incubated with anti-mouse F4/80 Ag-pan macrophage marker, BM8
primary Ab (1:300; eBioscience, San Diego, CA), and IgG control (1:300; eBioscience) in
PBS and 0.1% BSA for 30 min. Slides were washed with PBS and incubated with FITC
mouse anti-rat IgG (1:400; eBioscience) secondary Ab for 30 min, light protected. After
PBS washes, sections were coverslipped using Cytoseal containing DAPI (Vector
Laboratories, Burlingame, CA) and evaluated by fluorescence microscopy.
Bacterial clearance
The in vivo clearance of NTHi from the ME of TNF−/− and WT mice was determined by
culturing, on chocolate agar plates, 1 μl ME effusion from 6–10 MEs per time point and
condition on chocolate agar plates. MEs without effusion were scraped using a 1-μl loop to
recover any bacteria on the mucosal surface. CFUs per microliter were assessed after 24 h of
culture and analyzed semiquantitatively as described previously (9). The influence of TNF
and CCL3 was evaluated by pretreating mice with rCCL3 (50 ng/ml; eBioscience), rCCL3
plus rTNF (50 ng/ml; rTNF: R&D Systems) and an anti-mouse MIP-1α/CCL3Ab (10 μg/ml;
R&D Systems) 24 h prior to NTHi administration. MEs were evaluated for NTHi at 3 or 5 d.
All analyses were performed in at least duplicate. NTHi was verified by Gram-negative
staining of CFUs and by negative cultures on hemagglutinin versus chocolate agar plate.
Isolation and culture of peritoneal-derived macrophages
Primary peritoneal macrophages were obtained from six to nine TNF−/− and TLR2−/− mice
and control mice (WT) by i.p. injection of 3 ml thioglycolate medium. Cells were harvested
3 d later by peritoneal lavage with cold RPMI 1640, containing 10% FBS, 50 U/ml
penicillin, and 50 μg/ml streptomycin and β-mercaptoethanol, washed with media,
enumerated, and seeded into 48-well plates (5 × 105/well) in triplicates for each condition
and time point. For in vitro macrophage/NTHi interaction, cells were treated with rTNF (10–
100 ng/ml), rCCL3 (10–100 ng/ml), and rTNF plus rCCL3 (each 50 ng/ml) for 24 h in fresh
media without antibiotics.
Macrophage phagocytosis and killing assay
Phagocytosis and killing activities of macrophages were assessed using an established in
vitro assay (9). Midexponential phase NTHi were harvested from fresh cultures and
resuspended in PBS. Ten microliters (5 × 107/well), a titer that does not saturate the cells,
was added to give a ratio of bacteria to cells, ~100:1. The tissue culture plates were spun at
1000 rpm for 5 min to enhance contact between the bacteria and macrophages, and infected
monolayers were incubated with NTHi for 1 h at 37°C. Extracellular bacteria were removed
by washing with DMEM. Fresh DMEM containing 10% FCS, macrophage-CSF, and
gentamicin (50 μg/ml) was added to each well to ensure that the remaining extracellular
Leichtle et al. Page 4













bacteria were killed, leaving the intracellular bacteria intact, as gentamicin does not
penetrate the phagocytes. The minimum concentration of gentamicin required to kill
extracellular NTHi had previously been determined to be 1 μg/ml. At the end of 1 or 3 h, the
cells were rinsed and lysed using 0.5 ml pyrogen-free water followed by aspiration of the
lysate five times through a 23-gauge syringe. Lysates were plated on chocolate agar plates
and incubated overnight at 37°C in serial dilutions of 1:1 to 1:105 and evaluated by CFUs.
Six wells were used per time point and condition. The recovery of bacteria after macrophage
treatment with gentamicin for 1 h was used to represent phagocytosis. The ratio of bacteria
recovered after gentamicin treatment for 3 h over bacteria recovered posttreatment for 1 h
was taken to represent intracellular killing, similar to other published assays (9,32). Bacterial
killing percent was calculated as previously described (32) using the following formula:
killing % = [1 − (number of CFU in tested wells at 3 h with gentamycin treatment/number
of CFU in tested wells 1 h with gentamycin) × 100].
To assure that phagocytosis of NTHi by macrophages was not saturated at the bacterial dose
used, cultures were also exposed up to 5 × 108 /well, treated with gentamicin for 1 h, and
intracellular NTHi immediately recovered. Incubation with the 10-fold higher concentration
of 5 × 108 NTHi resulted in substantially more bacterial uptake than incubation with 5 × 107
NTHi (23.5 × 106 versus 0.85 × 105 CFU for WT macrophages; 11 × 106 versus 0.45 × 105
for TNF−/− macrophages). To determine whether the kinetics of intracellular bacterial
recovery was affected by TNF deletion and/or CCL3 treatment, intracellular bacterial
recovery in macrophages was assessed postincubation with 5 × 108 NTHi for 15 or 30 min
and 1, 2, 3, 5, and 9 h for both genotypes with or without rCCL3 treatment.
ELISA
Levels of CCL3 and TNF were measured in ME effusions post NTHi infection and in the
supernatants of macrophage cultures. ME effusions were sampled by extracting fluid from
the ME 24 h post NTHi inoculation, followed by rinsing with ELISA buffer. The ME
effusions, including the rinses, and the supernatants of the cell cultures were analyzed for
CCL3 and TNF content by ELISA using the DuoSet ELISA kit (R&D System) and
corrected for dilutions. Recombinant proteins were used to calibrate the assay, and the
sensitivity of the ELISA was 2 pg/ml for CCL3 and 12 pg/ml for TNF.
Detection of highly reactive oxygen species
Peritoneal macrophage superoxide production was evaluated by detection of highly reactive
oxygen species (hROS) using aminophenyl fluorescein, which fluoresces only in the
presence of hROS, such as free hydroxyl radical (·OH) and peroxynitrite (ONOO−) or major
macrophage hROS. Cells were treated with rTNF (50 ng/ml), rCCL3 (50 ng/ml), rTNF plus
CCL3 (each 50 ng/ml), or anti-mouse MIP-1α/CCL3 Ab (10 μg/ml). Macrophages were
resuspended in modified HBSS containing 10.0 μM HEPES, 1.0 μM MgCl2, 2.0 μM CaCl2,
and 2.7 μM glucose. Cells were loaded with aminophenyl fluorescein (10 μM; Cell
Technology, Columbia, MD) for 1 h at 37°C and infected with 5 × 107 NTHi. Luminescence
was measured in the live cells, and images were taken by fluorescence microscopy, followed
by image analysis with ImageJ (National Institutes of Health, Bethesda, MD) at 15 min. One
set of cells was fixed with PFA (4%) in PBS for 20 min and washed with PBS.
Postpermeabilization with Triton X-100 (5%; Sigma-Aldrich, St. Louis, MO) in PBS and
blocking in FBS (10%) for 20 min, macrophages were stained with DAPI (1:500) for 10
min, rinsed with PBS, and mounted (Vectastain, Vector Laboratories) for additional
imaging.
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One- and two-way ANOVA analysis, followed by Fisher post hoc test with Bonferroni
correction for multiple tests, was performed using StatView 5.0 software (JMP-SAS
Institute, Cary, NC). Differences between experimental groups were considered significant
at p < 0.05. The Mann-Whitney U test was used for data that was not normally distributed,
as in analyses of ME inflammatory cell numbers, bacterial clearance, and NTHi lysate
counts of the phagocytosis assay. For purposes of statistical analysis, left and right ears were
considered to be independent as described elsewhere (37).
Results
Lack of TNF alters the pathogenesis of OM
To determine the role of TNF in NTHi-induced OM, we initially examined the inflammatory
response to instillation of NTHi into the ME of mice lacking TNF and compared their
response to that of WT animals. Prior to inoculation of NTHi, the ME mucosa of noninfected
TNF−/− mice was significantly thicker than that of their noninfected WT counterparts. WT
mice, when exposed to NTHi, demonstrated an inflammatory response associated with
maximal mucosal thickness 2 d postinfection, with complete recovery noted by day 5. In
contrast, in the absence of TNF, the initial increase of mucosal thickness to NTHi noted in
WT mice was attenuated, but TNF−/− mice displayed marked and persistent mucosal
thickening at later times when WT mice have fully recovered from infection (Fig. 1A, 1B).
By days 2 and 3, both strains demonstrated a mucosal response of similar magnitude, but
distinct differences between WT and TNF−/− animals were noted after day 5, in which
TNF−/− mice displayed significantly increased mucosal thickness that persisted through the
last time point assessed on day 21.
Persistent OM in TNF−/− mice is associated with significantly decreased early gene
expression of IL-1β, CCL3, and TLR2
To investigate possible mechanisms for the altered inflammatory responses of TNF−/− mice,
we assessed expression of genes in the TLR-pathway triggered by NTHi in the ME mucosa
of WT and TNF−/− mice, at various times during the course of experimental OM (Fig. 1C).
NTHi triggered the rapid and transient expression of TNF mRNA in the WT ME at 6 h,
which rapidly declined to low levels after d 2. Expression of the proinflammatory genes
IL-1β, IL-6, CCL3, and CXCL2 displayed similar kinetics in response to NTHi infection in
WT mice, showing a rapid increase at 6 h, but more modest increases from day 2 through
day 5 (Fig. 1C). Compared to the responses noted in ME mucosa of WT mice, in the ME
mucosa of TNF−/− animals, expression of these genes was significantly higher than in WT
mice prior to infection (time 0), but strikingly, a rapid fall in their expression was seen post
NTHi inoculation (Fig. 1C). This was particularly true for the expression of IL1β and CCL3.
Expression of genes encoding TLR molecules was also altered in response to NTHi in
TNF−/− as compared with WT mice. In WT mice, TLR2 gene expression was significantly
increased at 6 h and 1 d postinfection, whereas TLR4 expression was not (Fig. 1C). In
contrast, in TNF−/− mice, the genes for both TLR2 and TLR4 were expressed at higher levels
than in WT mice prior to infection, but mRNA levels for these molecules decreased below
the detection threshold soon after NTHi challenge.
Absence of TNF is associated with diminished but prolonged neutrophil recruitment,
increased and persistent recruitment of macrophages, decreased CCL3 protein
expression, and a failure to clear NTHi from the ME cavity
The two main effect or cells in clearance of bacteria in this murine model of OM are
neutrophils and macrophages. In WT mice, neutrophils were the dominant cell type
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identified during initial stages of inflammation, rapidly emigrating into the ME lumen with
in 6 h of NTHi inoculation. Macrophage accumulation followed at day 2 through dat 5 (Fig.
2A, 2B), with smaller numbers of these cells than of neutrophils. By day 10, the ME cavity
was cleared of both cell types in WT mice. This classic pattern of inflammatory cell
recruitment was significantly altered in the absence of TNF, where the initial recruitment of
neutrophils into the ME cavity was strongly compromised, never reaching the peak seen in
WT animals. However, neutrophils persisted through day 21 (Fig. 2A). In contrast to WT
mice, macrophages were the dominant cell type recruited to the ME of TNF−/− mice (Fig.
2B, 2C), appearing earlier at 6 h and persisting until day 21. Their numbers in the ME were
also consistently greater than in WT mice. TNF and CCL3 protein levels were evaluated in
ME effusions 1 d post NTHi inoculation (Fig. 2D). In WT mice, TNF was below the
detection threshold prior to bacterial inoculation and increased to 1.0 (± 1.4) ng/ml in
response to NTHi. CCL3 was also undetectable in the naive WT or TNF−/− MEs, but
increased to 17.0 (± 3.75) ng/ml postinoculation with NTHi in WT mice but to only 7.5 (±
1.25) ng/ml in TNF−/− MEs (p < 0.01).
Next, we assessed the presence of NTHi organisms in the ME cavity of WT and TNF−/−
mice (Fig. 2E). Viable NTHi were completely cleared by day 5 in WT mice. In TNF−/−
mice, however, the bacterial load recovered from the ME cavity was not only consistently
and significantly higher than that obtained from WT mice, but also persisted through day 21,
the last time point that we examined (Fig. 2E). Thus, the persistent inflammation seen in the
ME of TNF−/− mice, which was accompanied with suppressed gene and protein expression
of proinflammatory cytokines, chemokines and TLRs, is functionally associated with an
altered capacity to clear NTHi in murine OM.
Bacterial phagocytosis and intracellular killing by peritoneal macrophages are impaired in
the absence of TNF
Because TNF−/− mice failed to clear NTHi from ME cavity despite more accumulation of
macrophages in the ME lumen, we hypothesized that attenuated macrophage function
underlies the aberrant response in the ME of TNF−/− mice. We therefore evaluated the
phagocytic and intracellular killing capacity of peritoneal macrophages derived from WT
and TNF−/− mice in vitro (Fig. 3A). Compared to macrophages obtained from WT mice,
macrophages from TNF−/− animals showed significantly impaired phagocytic function,
demonstrated by decreased uptake of NTHi at 1 h. Additionally, at 3 h, macrophages from
TNF−/− mice exhibited reduced intracellular killing of the bacteria when compared with WT
cells (Fig. 3A).
To further explore the mechanism for these functional deficits, we evaluated the expression
of genes in macrophages likely involved in their ability to phagocytose and kill NTHi (Fig.
3B). Regardless of the genotype, we could not detect gene expression of CCL3, IL-1β, or
CXCL2, known to be produced by activated macrophages and (with the exception of IL-1β)
known to be involved in phagocytosis and killing in naive macrophages not exposed to
NTHi. However, all of these genes were upregulated by NTHi in both genotypes, although
gene expression of CCL3 and IL-1β was substantially decreased in TNF−/− macrophages
(Fig. 3B). Similar to TNF−/− macrophages, we found decreased expression of CCL3 and
TNF mRNA in TLR2−/− macrophages when compared with WT macrophages post NTHi
infection, suggesting that TLR2 senses NTHi in macrophages (Supplemental Fig. 1).
Although mRNA encoding TLR2 and TLR4 was detectible prior to NTHi challenge in both
TNF−/− and WT macrophages, TNF−/− macrophages expressed significantly lower levels of
both (Fig. 3B). After NTHi challenge, TLR2 mRNA increased in macrophages of both
genotypes, with a significantly higher expression in WT macrophages. As noted in vivo in
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the ME mucosa, TLR4 expression in macrophages strongly decreased after NTHi infection in
both WT and TNF−/− mice.
Exogenous rTNF partially restores phagocytosis and intracellular killing capacity and
induces expression of CCL3 in macrophages derived from TNF−/− mice
In an attempt to understand the mechanism underlying the impaired function seen in TNF−/−
animals in vivo and in vitro, we next assessed the effect of the addition of individual
mediators upon the ability of macrophages to phagocytose and kill NTHi. Macrophages from
WT mice responded to rTNF stimulation with a strong and dose-dependent increase in their
ability to phagocytose NTHi (Fig. 4A). They also showed increased intracellular killing (Fig.
4B). Stimulation of TNF−/− macrophages with rTNF significantly increased phagocytic
capacity in a dose-dependent manner, but only to a level ~60% of that observed in
unstimulated WT mice, with the highest response seen at 50 ng/ml rTNF (Fig. 4A).
Similarly, a dose-dependent improvement in bacteriocidal capacity was observed in TNF−/−
macrophages, but it remained deficient when compared with unstimulated WT even at a
dose of 100 ng/ml rTNF (Fig. 4B). To further explore the effects of rTNF on macrophage
behavior, we next assessed its effect on the expression of genes known to be increased in
macrophages in response to NTHi. In the absence of NTHi, no CCL3 mRNA was expressed
by macrophages of either genotype in response to any concentration of exogenous rTNF.
However, rTNF resulted in an approximate doubling of NTHi-triggered increase of CCL3
expression in macrophages from both WT and TNF−/− mice, with consistently lower
expression in TNF−/− macrophages (Fig. 4C). In response to rTNF, a modest and
comparable augmentation of NTHi-induced mRNA encoding CXCL2 was noted in both cell
types. IL-1β mRNA was modestly augmented by rTNF in WT but not in TNF−/−
macrophages. rTNF also suppressed the NTHi-induced TLR2 mRNA expression in both
genotypes, but did not alter the expression of mRNA for TLR4 seen in TNF−/− mice (not
shown).
Interestingly, the level of CCL3 protein as measured by ELISA in both WT and TNF−/−
macrophage supernatants was significantly increased at 6 and 24 h in response to NTHi,
although the increase was less in TNF−/− macrophages (Fig. 4D). However, CCL3 protein
was increased by exposure to 10–100 ng/ml rTNF in macrophages from TNF−/− mice at 24
h to levels similar to those observed in WT macrophages in response to NTHi alone (Fig.
4D).
Exogenous rCCL3 improves phagocytosis and killing by macrophages from TNF−/− mice
The finding that CCL3 gene expression was augmented in macrophages from WT and
TNF−/− animals and that CCL3 protein levels were fully restored in macrophages from
TNF−/− mice by exogenous rTNF led us to examine the role of CCL3 in modulating the
phagocytic and bacteriocidal function of macrophages. Exogenous rCCL3 strongly
enhanced phagocytosis of NTHi by macrophages from WT mice, but only modestly
enhanced intracellular killing. In TNF−/− macrophages, the addition of graded amounts of
CCL3 restored both phagocytosis and killing functions in a dose-dependent manner to a
level indistinguishable from those of WT mice responding to NTHi alone (Fig. 5A, 5B).
Although the response of TNF−/− macrophages was less than that of WT cells, rCCL3 was
more effective in restoring these functions than the addition of an equivalent concentration
of rTNF (Fig. 5B). The addition of both rCCL3 and rTNF (50 ng/ml each) to TNF−/−
macrophages proved most potent in augmenting phagocytosis and bacterial killing by these
cells (Fig. 5A, 5B).
When WT and TNF−/− macrophages were incubated with NTHi for various periods,
bacterial recovery from macrophages was low at 15 and 30 min, but was substantially
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increased (p < 0.001) at 1 h (Supplemental Fig. 2). When bacteria were left on the cells for 2
or 3 h, recovery of bacteria declined sharply in WT cells. However, the peak of bacterial
recovery was observed at 2 h in TNF−/− macrophages, suggesting delayed phagocytosis and
impaired intracellular killing in the absence of TNF. NTHi recovery declined slightly at 3 h
in TNF−/− cells. Significantly fewer bacteria were recovered at 2 to 3 h from TNF−/−
macrophages stimulated with CCL3 (p < 0.001), consistent with the enhanced intracellular
killing shown in Fig. 5B. At 5 and 9 h, bacteria were recovered only from TNF−/−
macrophages without CCL3 stimulation (not shown).
In contrast to rTNF (Fig. 4C), exogenous rCCL3 significantly induced the expression of
CXCL2 mRNA in both genotypes, whereas IL-1β gene expression was augmented by rCCL3
in WT but not in TNF−/− cells, similar to the effect of rTNF. rCCL3 did not have any effects
on TLR2 or TLR4 mRNA expression in both genotypes, in contrast to TLR2 mRNA
suppression by rTNF.
rCCL3 and rTNF induce hROS production in NTHi-exposed macrophages
rCCL3 stimulated the intracellular killing in TNF−/− macrophages significantly more than
rTNF and did so to a level seen in WT macrophages exposed to NTHi in the absence of
exogenous cytokines. To further elucidate the nature of the bacteriocidal defects in TNF−/−
mice, we investigated the production of hROS by macrophages of WT and TNF−/− mice in
response to NTHi in the presence or absence of rTNF or rCCL3, alone or in combination.
Indeed, NTHi-infected cells, but not uninfected ones, expressed cytoplasmic hROS at 15 min
postexposure to bacteria, although significantly fewer hROS-positive TNF−/− macrophages
were observed than in WT macrophages (Fig. 6). Addition of rTNF or rCCL3 alone as well
as their combined addition further increased the production of hROS in NTHi exposed
macrophages of both genotypes. The hROS production of TNF−/− macrophages was
restored by rTNF to the level seen in WT cells in response to NTHi alone. Generation of
hROS was augmented even more in TNF−/− macrophages in response to exogenous rCCL3
given alone or with rTNF.
rCCL3 improves the clearance of NTHi from the ME of TNF−/− animals in vivo
To extend our in vitro observations to the in vivo model of OM, we treated WT and TNF−/−
mice with rCCL3, rCCL3 plus rTNF, or with a neutralizing Ab against CCL3 24 h
preinfection with NTHi. The levels of rCCL3 and rTNF employed for this one-time
administration (50 ng/ml) were substantially higher than those we observed in either the WT
or TNF−/− ME 24 h post NTHi inoculation (Fig. 2D) and were chosen to ensure that
sufficient mediator was present throughout the experiment. Anti-CCL3 pretreatment
impaired the ability of WT mice to clear NTHi from the ME at 3 and 5 d when compared
with buffer-treated control animals (Fig. 7). TNF−/− mice, which normally fail to clear
bacteria from the ME (Fig. 2A), showed significantly improved bacterial clearance at days 3
and 5 after pretreatment of their MEs with rCCL3 alone. This protective effect was further
enhanced by pretreatment with the combination of rCCL3 and rTNF (Fig. 7), such that the
antibacterial defects noted in TNF−/− animals were fully recovered.
Discussion
Antimicrobial activity mediated by innate immunity is central to the host response to
infection. Deficiencies in key innate immune signaling molecules, such as TLR2 and
MyD88, have been shown experimentally to increase the severity of infections and to be
associated with impaired phagocytosis and killing of bacteria (9,10,39,40). Moreover,
mutations and polymorphisms in the TLR/MyD88 signaling axis have been associated with
increased incidence and severity of infections in humans (12,29). We have recently
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demonstrated that TNF, a downstream mediator of innate immunity, is a major target of
signaling through TLR2 and TLR4 in NTHi-induced OM and is strongly downregulated in
the absence of either TLR (10). TNF is known to play both positive and negative feedback
roles in TLR signaling through its ability to regulate the expression of TLRs and other
inflammatory genes via NF-κB (41,42).
Because TNF expression is increased during normal responses to experimental OM in mice,
and its expression is suppressed in animals not able to properly clear OM due to lack of TLR
signaling molecules, we have assessed the role of TNF during OM in mice. Infection of the
MEs of TNF−/− mice resulted in aberrant and prolonged inflammation as manifested by
thickening of the ME mucosa (Fig. 1A, 1B) and impaired clearing of bacteria from the ME
(Fig. 2E). Interestingly, this was accompanied by a dramatic decrease of proinflammatory
genes that are normally increased during NTHi infection in WT mice (Fig. 1C). Recruitment
of polymorphonuclear leukocytes (Fig. 2A) to the ME in response to NTHi was significantly
reduced in TNF−/− animals, whereas, in contrast, that of macrophages occurred earlier and
persisted for much longer than in WT animals (Fig. 2B). Despite the prolonged presence of
inflammatory leukocytes, bacteria were not cleared from the ME in TNF−/− mice. Moreover,
macrophages derived from TNF−/− animals were defective in their ability to phagocytose
and kill NTHi (Fig. 3).
As bacteria are known to drive inflammation in this model, the inefficient killing of NTHi
noted in TNF−/− mice may have, at least in part, mediated the prolonged mucosal thickening
and cellular infiltration noted in these animals. The early influx of mononuclear leukocytes
seen in TNF−/− animals may have been mediated by CXCL2, because gene expression of
this chemokine was elevated in TNF−/− animals prior to NTHi infection (Fig. 1C). The
failure of macrophages to clear from the ME, despite reduced CCL3 and a probable
reduction in macrophage migration inhibiting factor (known to be induced by TNF) (43), is
presumably due to persistence of NTHi. The continued presence of macrophages in the MEs
of TNF−/− mice during experimental OM is reminiscent of that seen in a severe colitis
model in this strain (44) but differs from the reduced macrophage infiltration of the lung
seen in mycobacterial infection of mice lacking TNF (45).
The absence of TNF was also accompanied by diminished expression of genes encoding
TLR2, TLR4, CCL3, and IL-1β in response to NTHi in the ME mucosa (Fig. 1C). TLR2 is an
important receptor for bacterial pathogen-associated molecular patterns found in NTHi (18),
whereas CCL3 is a critical mediator in the recruitment and activation of PMNs and
macrophages (31,46-48). In any event, the alterations seen in TNF−/− mice in response to
ME bacterial infection are consistent with an important role for TNF in regulating and
amplifying responses to TLR signaling. As TNF, the β form of pro-IL-1 signaling, and
CCL3 activation are important in neutrophil recruitment in other models (46,47), their
dysregulation in TNF−/− animals provides an additional mechanism for the altered
inflammatory responses reported in this study.
Critical to the persistent inflammation and bacterial presence in this model is the impaired
function of macrophages, decreased rate of phagocytosis, and compromised ability to kill
intracellular bacteria. Defects in macrophage function identified in TNF−/− mice appear to
be related to the effect of TNF on downstream effector molecules. In the absence of TNF,
the ability of NTHi to activate macrophages in vitro was reduced, as exemplified by their
diminished expression of genes for the downstream molecules CCL3 and the β form of pro-
IL-1 and for the upstream receptor TLR2 (Fig. 3). Such reduced expression would be
expected to impair the in vivo antimicrobial function of macrophages from TNF-deficient
animals and to reduce recruitment of PMNs into the ME cavity. Reduced production of
hROS in macrophagers lacking TNF would be expected to decrease bacterial killing.
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The addition of exogenous rTNF to macrophages derived from TNF−/− animals partially
restored their ability to phagocytose and kill NTHi (Fig. 4A, 4B). The inability of TNF to
fully restore these functions suggests long-term changes in the cellular response to this
cytokine perhaps mediated by stable changes in receptors or downstream targets. This idea
is further supported by the altered expression of genes for TLR2 and CXCL2 in response to
rTNF in TNF−/− macrophages compared with WT cells (Fig. 4C).
rTNF was able to enhance CCL3 gene and protein expression in TNF−/− macrophages, but
not to the extent seen in cells derived from WT mice (Fig. 4C, 4D). This may be a critical
difference, as CCL3 treatment restored most of the responses seen in WT cells:
phagocytosis, bacterial killing, gene expression, and hROS production were all markedly
responsive to exogenous rCCL3 in TNF−/− macrophages (Figs. 5, 6). As with rTNF, the fact
that TNF−/− cells were less responsive to rCCL3 than WT cells suggests stable changes in
the receptor and/or signaling repertoires of these cells. It should also be noted that the effect
of rCCL3 on NTHi phagocytosis was not simply an effect on kinetics, because the relative
increase in NTHi uptake over time was similar in untreated and in rCCL3-treated WT
macrophages.
These latter findings support the hypothesis that TNF acts through this downstream
chemokine in regulating macrophage function. The results also demonstrate that
macrophages from TNF−/− mice are capable of normal function, only requiring appropriate
activation to fulfill their role in control of bacterial infection. The functional importance of
CCL3 to macrophages is illustrated by the restoration of hROS production and NTHi killing
capacity of TNF−/− macrophages by rCCL3 alone or in combination with rTNF (Figs. 5B,
6A). Of broader significance is the ability of rCCL3, alone or in combination with rTNF, to
rescue the ability of TNF−/− mice to clear NTHi in vivo and the ability of the Ab to CCL3 to
impair clearance of bacteria from WT mice. These findings identify CCL3 as a critical
mediator of TNF function and an essential component of the normal response to bacterial
infection in the ME and perhaps in other sites as well.
Enhanced bacterial phagocytosis and killing by human and murine macrophages in response
to rCCL3 has been previously reported (32,49). However, our studies provide evidence that
induction of CCL3 plays a central role in macrophage biology. It also appears likely that full
expression of TNF function requires a critical level of CCL3.
As defects in TLR signaling, including IL-1R-associated kinase 4 and MyD88 deficiency
(50,51) or disturbed TNF production (13,29,30), increase susceptibility to infections in
children, the importance of innate immune signaling in host defense against bacterial disease
is underscored (52). We have reported previously that the absence of TLR2, TLR4, or
MyD88 (9,10) results in defective bacterial clearance and persistent OM in mice, similar to
that seen in TNF−/− animals. Because TNF is a major downstream product of TLR/MyD88
signaling, it is therefore possible that CCL3 would rescue the phenotypes of these mice as
well. This idea is supported by the impaired expression of TNF and CCL3 mRNA by
TLR2−/− macrophages, observed in response to NTHi (Supplemental Fig. 1). These data
suggest that CCL3 is a crucial component of NTHi-signaling and that many innate immune
responses to NTHi may be mediated by a TLR2/TNF-mediated CCL3 response.
In summary, we show that in a murine model of OM, the absence of TNF is associated with
aberrant inflammatory responses, defective macrophage function, and prolonged OM.
rCCL3 can rescue the abnormal response of TNF−/− mice both in vitro and in vivo and also
enhance the function of WT macrophages, suggesting that this chemokine is a central
effector in OM and a potential therapeutic target for persistent disease.
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TNF−/− mice develop persistent mucosal thickness and decreased initial inflammatory gene
expression during NTHi-induced OM. A, Time course of mucosal thickness in response to
NTHi in WT (closed bars) and TNF−/− mice (open bars). Results are expressed as means ±
SEM of six MEs. B, Histologic changes in MEs of WT (left panels) and TNF−/− (right
panels) mice at 2 d (top panels), 5 d (middle panels), and 10 d (lower panels) postinstillation
of NTHi in the ME (original magnification ×100). Arrows denote mucosa. C, Relative
mRNA expression measured by qRT-PCR of selected downstream cytokine/chemokine
genes and TLR2 and TLR4 in ME mucosa prior to and post NTHi instillation into the ME of
WT (solid lines) and TNF−/− (broken lines) mice. Target transcripts of WT and TNF−/−
MEs were normalized to GAPDH and compared with uninfected mucosa of WT animals (0
h). Experiments were performed in triplicate and evaluated using two-way ANOVA and
Fisher post hoc test with Bonforroni correction (*p < 0.05; **p < 0.01; ***p < 0.001, for
this and subsequent figures).
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TNF−/− MEs display impaired bacterial clearance and neutrophil recruitment, but increased
macrophage presence post NTHi infection. The numbers of neutrophils (A) and macrophages
(B) in the ME cavity of WT (closed bars) and TNF−/− (open bars) mice per ×400 high-
power field of H&E and immunostained specimens (n = 6). C, Immunohistochemical
identification of macrophages in ME of WT (left panel) and TNF−/− (right panel) mice at 3,
5, and 10 d postinstillation of NTHi (original magnification ×400). Macrophages were
stained with monoclonal anti-mouse F4/80 Ab and FITC mouse anti-rat IgG (green) and
nuclei are stained with DAPI (blue). Autofluorescence (yellow) represent erythocytes in the
ME cavity. Arrows denote macrophages. D, ME cell effusion was assessed for TNF and
CCL3 protein by ELISA 1 d post NTHi-inoculation from WT and TNF−/− mice.
Experiments were performed in triplicate and expressed as means ± SEM from individual
mice. E, Bacterial presence as CFUs detected in the MEs of WT and TNF−/− mice
postinstillation of NTHi. CFUs per microliter sample loop identified after 24 h of bacterial
culture are displayed (n = 6).
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Phagocytosis and killing of bacteria by TNF−/− macrophages is impaired and is associated
with decreased expression of the genes for CCL3, IL-1β, and TLR2. A, Phagocytosis and
killing of NTHi bacteria was assessed in peritoneal macrophages from WT (closed bars) and
TNF−/− (open bars) mice. Bacteria remaining after 1 h (phagocytosis) and 3 h (killing) were
quantified by colony counting. B, Expression of genes for CCL3, CXCL2, IL-1β, TLR2, and
TLR4 after 6 h exposure of macrophages from WT and TNF−/− mice to NTHi was
determined by qRT-PCR. Experiments were performed in triplicate and expressed as means
± SEM. Data are representative of three independent experiments.
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rTNF augments phagocytic and killing activity of TNF−/− macrophages and induces an
NTHi-dependent increase of CCL3 expression. Peritoneal-derived macrophages from WT
(closed bars) and TNF−/− (open bars) mice were stimulated in vitro with varying
concentrations of rTNF for 24 h before infection with NTHi. Phagocytosis (A) and killing
(B) of NTHi was assessed. Killing is displayed as the percentage of phagocytosed NTHi. C,
Expression of genes for selected cytokines, chemokines, and TLR2 by macrophages from
WT and TNF−/− mice after 6 h exposure to NTHi in the presence or absence of varying
concentrations of rTNF. Gene expression by qRT-PCR was normalized to GAPDH and
compared using WT at 0 h as baseline. D, CCL3 protein assessed by ELISA (pg/ml) in
supernatant of macrophages from WT and TNF−/− mice at 6 and 24 h postexposure to NTHi
in the presence or absence of varying concentrations of rTNF. Experiments were performed
in triplicate and expressed as means ± SEM from individual mice.
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rCCL3, alone or with rTNF, enhances phagocytosis and killing of NTHi by macrophages of
TNF−/− mice and induces gene expression of CXCL2. Phagocytosis (A) and killing (B) of
NTHi by macrophages from WT (closed bars) and TNF−/− (open bars) mice in the presence
or absence of varying concentrations of rCCL3 alone or in combination with 50 μg/ml
rTNF. C, Expression of selected genes from macrophages of WT and TNF−/− mice from cell
lysates obtained 6 h postexposure to NTHi in the presence or absence of rCCL3 with or
without 50 μg rTNF. mRNA levels were assessed using qRT-PCR and normalized to
GAPDH. Data are expressed as means ± SEM and represent one of three independent
experiments, each performed in triplicate.
Leichtle et al. Page 20














rCCL3 and rTNF restore impaired hROS production by TNF−/− macrophages in response to
NTHi. A, The percentage of macrophages from WT (closed bars) and TNF−/− (open bars)
mice expressing hROS before and after 15 min incubation with NTHi in the presence or
absence of 50 μg rCCL3 or rTNF or both or in the presence of Ab to CCL3. B,
Photomicrographs of hROS production by macrophages from WT (top panels) and TNF−/−
(lower panels) mice in response to NTHi with (right panels) and without (left panels) rTNF
plus rCCL3. Original magnification ×100. C, Fluorescent localization of hROS (green) in
the cytoplasm of WT macrophages exposed to NTHi for 15 min. Nuclei were stained with
DAPI (blue). Original magnification ×400.
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Microbial clearance from the ME of WT and TNF−/− mice in vivo in the presence or
absence of rCCL3 alone or in combination with rTNF. The presence of bacteria was
quantified in MEs of WT (closed bars) and TNF−/− (open bars) mice at 3 d (A) and 5 d (B)
postexposure to NTHi in the presence of diluent control (FBS) or anti-rCCL3 (WT mice) or
rCCL3 alone or together with rTNF (TNF−/− mice). Data are expressed as means ± SEM.
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